We are live on
!
Find out more
AQR Capital Management Portfolio holdings
AUM
$218B
1-Year Est. Return
29.41%
This Fund
S&P 500
This Quarter
Est. Return
+4.84%
1 Year Est. Return
+29.41%
3 Year Est. Return
+92.15%
5 Year Est. Return
+116.61%
10 Year Est. Return
+435.72%
AUM
$191B
AUM Growth
+$34.6B
(+22%)
Cap. Flow
+$29.9B
Cap. Flow
% of AUM
15.69%
Top 10 Holdings %
Top 10 Hldgs %
11.5%
Holding
3,667
New
211
Increased
2,098
Reduced
1,163
Closed
105
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Atlassian
TEAM
|
+$905M |
| 2 |
Bristol-Myers Squibb
BMY
|
+$786M |
| 3 |
NVIDIA
NVDA
|
+$736M |
| 4 |
Centene
CNC
|
+$642M |
| 5 |
Apple
AAPL
|
+$451M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Molina Healthcare
MOH
|
+$415M |
| 2 |
Intel
INTC
|
+$329M |
| 3 |
General Motors
GM
|
+$237M |
| 4 |
DoorDash
DASH
|
+$225M |
| 5 |
Intuit
INTU
|
+$187M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 23.3% |
| 2 | Financials | 15.19% |
| 3 | Healthcare | 12.58% |
| 4 | Consumer Discretionary | 12.42% |
| 5 | Industrials | 12.23% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
76
Accenture
ACN
$108B
| $489M | 0.26% |
1,823,851
+571,517
| +46% | +$145M |
|
77
Mastercard
MA
$495B
| $485M | 0.25% |
849,404
-11,889
| -1% | -$6.65M |
|
78
Amphenol
APH
$210B
| $485M | 0.25% |
3,587,990
-222,851
| -6% | -$29.8M |
|
79
IQVIA
IQV
$39.7B
| $482M | 0.25% |
2,139,228
+361,528
| +20% | +$78.7M |
|
80
ExxonMobil
XOM
$655B
| $480M | 0.25% |
3,984,577
+1,059,551
| +36% | +$123M |
|
81
State Street SPDR S&P 500 ETF Trust
SPY
$811B
| $479M | 0.25% |
702,909
+128,776
| +22% | +$87M |
|
82
Gartner
IT
$12B
| $477M | 0.25% |
1,892,004
+646,052
| +52% | +$155M |
|
83
HubSpot
HUBS
$10.6B
| $477M | 0.25% |
1,188,981
+642,545
| +118% | +$266M |
|
84
Tyson Foods
TSN
$20.3B
| $476M | 0.25% |
8,114,441
+1,387,645
| +21% | +$76.2M |
|
85
Palo Alto Networks
PANW
$310B
| $474M | 0.25% |
2,574,751
+478,209
| +23% | +$96.5M |
|
86
Tapestry
TPR
$32.5B
| $468M | 0.25% |
3,666,736
-640,879
| -15% | -$73.3M |
|
87
Textron
TXT
$15.4B
| $467M | 0.25% |
5,357,182
+1,811,787
| +51% | +$152M |
|
88
Mueller Industries
MLI
$15.4B
| $465M | 0.24% |
8,109,130
+2,937,744
| +57% | +$158M |
|
89
MarketAxess Holdings
MKTX
$5.72B
| $464M | 0.24% |
2,558,097
+1,607,009
| +169% | +$274M |
|
90
Neurocrine Biosciences
NBIX
$16.6B
| $463M | 0.24% |
3,271,706
+498,058
| +18% | +$72.2M |
|
91
AT&T
T
$162B
| $461M | 0.24% |
18,578,846
+2,445,270
| +15% | +$61.9M |
|
92
JPMorgan Chase
JPM
$957B
| $454M | 0.24% |
1,410,392
-313,206
| -18% | -$97M |
|
93
Citizens Financial Group
CFG
$30.7B
| $451M | 0.24% |
7,722,559
+2,799,050
| +57% | +$150M |
|
94
Tenet Healthcare
THC
$21.1B
| $448M | 0.24% |
2,256,539
+380,116
| +20% | +$76.8M |
|
95
Texas Roadhouse
TXRH
$13.9B
| $444M | 0.23% |
2,674,102
+575,685
| +27% | +$97.4M |
|
96
Freeport-McMoran
FCX
$99.1B
| $441M | 0.23% |
8,679,316
+3,063,673
| +55% | +$133M |
|
97
Cigna
CI
$74.3B
| $440M | 0.23% |
1,598,091
+781,349
| +96% | +$219M |
|
98
Progressive
PGR
$125B
| $435M | 0.23% |
1,909,426
+683,160
| +56% | +$154M |
|
99
New York Times
NYT
$10.5B
| $433M | 0.23% |
6,241,489
+1,628,200
| +35% | +$101M |
|
100
Delta Air Lines
DAL
$59.2B
| $426M | 0.22% |
6,155,776
+1,890,521
| +44% | +$118M |
|
Similar funds
VGA
AQR Capital Management's Q4 2025 Portfolio in Review
As of Q4 2025, AQR Capital Management held 3,667 positions worth $191B, up 22% from $156B the previous quarter. Its ten largest holdings account for 12% of the portfolio.
AQR Capital Management deployed $29.9B of net new capital in Q4 2025, opening 211 new positions and adding to 2,098 existing holdings. Its largest new stake was Celestica: 1,066,543 shares worth $315M.
By sector, the portfolio is most concentrated in Technology at 23% of assets, down from 25% a quarter earlier, followed by Financials and Healthcare.
On the sell side, the largest reduction was Molina Healthcare, an estimated $415M trimmed.
- AQR Capital Management's largest Q4 2025 buy was Celestica: 1,066,543 shares worth $315M.
- AQR Capital Management added most to Atlassian in Q4 2025, an estimated $905M increase.
- AQR Capital Management's biggest Q4 2025 reduction was Molina Healthcare, cutting an estimated $415M.
- AQR Capital Management fully exited Light & Wonder in Q4 2025, selling an estimated $70.7M.
- AQR Capital Management's ten largest holdings make up 12% of its $191B portfolio in Q4 2025.
- AQR Capital Management opened 211 new positions and closed 105 in Q4 2025.
- AQR Capital Management's portfolio value rose 22% quarter-over-quarter to $191B.
Based on AQR Capital Management's 13F filing for Q4 2025, filed 17 Feb 2026.